Skip to main content
Clinical Trials/NCT03079830
NCT03079830
Completed
Not Applicable

Efficacy of Ropivacaine Wound Infiltration for Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery

University Medical Centre Ljubljana1 site in 1 country76 target enrollmentOctober 2016

Overview

Phase
Not Applicable
Intervention
Piritramid
Conditions
Aortic Valve Surgery
Sponsor
University Medical Centre Ljubljana
Enrollment
76
Locations
1
Primary Endpoint
Comparison of cumulative postoperative dose of Piritramid between the two different protocols, using VAS scale to determine level of analgesia.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The study evaluates the efficacy of local anesthestic application through the catheter in the surgical wound for the postoperative pain relief after minimally invasive aortic valve surgery. The patients will be enrolled in two different groups according to the protocol of the local anesthetic and saline administration:

  1. group: continous infusion of the local anesthetic plus bolus on demand
  2. group: continous infusion of saline plus bolus on demand For all patients metamizol every 12 hours plus bolous of piritramid on demand.

Detailed Description

Patients undergoing minimally invasive aortic valve replacment surgery will be enroled in the study, after giving a signed informed consent. The study evaluates the efficacy of local anesthestic application through the catheter in the surgical wound for the postoperative pain relief after minimally invasive aortic valve surgery. Patients will then be randomised in two groups according to the protocol: 1. group: continous infusion of the local anesthetic plus bolus on demand 2. group: continous infusion of saline plus bolus on demand All patients will receive Metamizol every 12 hours plus bolus of piritramid on demand. Analgesia effectivness will be checked hourly according to the visual analogue scale (VAS). According to protocol, bolus will be given every time the score of VAS scale is \>3. The catheter will be removed 48 hours after the protocols' start.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
January 11, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maja Sostaric

asoc. prof.

University Medical Centre Ljubljana

Eligibility Criteria

Inclusion Criteria

  • Patients after minimally invasive aortic valve surgery
  • Patients agreement with the study

Exclusion Criteria

  • Age under 18 years
  • Allergy to local anesthetic

Arms & Interventions

Ropivacaine continous infusion

Piritramid

Intervention: Piritramid

Saline continous

Piritramid

Intervention: Piritramid

Saline continous

Piritramid

Intervention: Saline

Outcomes

Primary Outcomes

Comparison of cumulative postoperative dose of Piritramid between the two different protocols, using VAS scale to determine level of analgesia.

Time Frame: 48 hours after admission to the intensive care unit (ICU)

Comparison of cumulative postoperative dose of Piritramid between the two protocols

Secondary Outcomes

  • Hospital lenght of stay(Up to 30 days)
  • Patients satisfaction with pain relief measured by Likert-type Patient satisfaction scale(72 hours after surgery)
  • Visual analogue scale (VAS), frequency of scores higher than 3(48 hours after admission to the ICU)
  • Rate of complications related to the local anesthetic(72 hours after surgery)
  • Complications related to the catheter in the surgical wound(Up to 30 days)

Study Sites (1)

Loading locations...

Similar Trials